(19)
(11) EP 1 039 933 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
20.12.2006 Bulletin 2006/51

(45) Mention of the grant of the patent:
08.02.2006 Bulletin 2006/06

(21) Application number: 98958518.7

(22) Date of filing: 10.11.1998
(51) International Patent Classification (IPC): 
A61K 47/48(2006.01)
(86) International application number:
PCT/US1998/023957
(87) International publication number:
WO 1999/024066 (20.05.1999 Gazette 1999/20)

(54)

METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE RESPONSE AND FOR THE PRODUCTION OF $i(IN VITRO) MABS

METHODEN UND ZUSAMMENSETZUNGEN ZUR ERHÖHUNG DER IMMUNANTWORT UND ZUR HERSTELLUNG VON IN-VITRO MONOKLONALEN ANTIKÖRPERN (MABS)

TECHNIQUES ET COMPOSITIONS AFFERENTES VISANT A RENFORCER UNE REPONSE IMMUNITAIRE ET PERMETTANT DE PRODUIRE DES ANTICORPS MONOCLONAUX (AcM)

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 10.11.1997 US 65155 P
24.02.1998 US 75811 P
06.11.1998 US 107455 P

(43) Date of publication of application:
04.10.2000 Bulletin 2000/40

(73) Proprietor: CYTIMMUNE SCIENCES, INC.
Rockville, MD 20850 (US)

(72) Inventors:
  • TAMARKIN, Lawrence
    Rockville, MD 20854 (US)
  • PACIOTTI, Giulio, F.
    Baltimore, MD 21075 (US)

(74) Representative: Viering, Jentschura & Partner 
Postfach 22 14 43
80504 München
80504 München (DE)


(56) References cited: : 
EP-A- 0 044 722
EP-A- 0 667 398
WO-A-96/04313
 EP-A- 0 179 483
WO-A-94/21288
US-A- 5 126 253
   
  • PETERS D.K., ET AL.: "Binding and internalization of biotinylated interleukin-2 in human lymphocytes" BLOOD, vol. 76, no. 1, 1 July 1990 (1990-07-01), pages 97-104, XP002108307
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).